Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hooper

Showing results (421-430 of 470) with videos related to

Pageof 47
Sort By:
The Journal of Biological Chemistry|October 16, 1999
The T-superfamily of conotoxinsC S Walker, D Steel, R B Jacobsen, et al.
Frontiers in Neurology|April 1, 2021
Sustained Clinical Improvement in a Subset of Patients With Progressive Multiple Sclerosis Treated With Epstein-Barr Virus-Specific T Cell TherapyZara A Ioannides, Peter A Csurhes, Nanette L Douglas, et al.
Annals of the New York Academy of Sciences|January 1, 1976
Immunochemotherapy of lung cancerT H Stewart, A C Hollinshead, J E Harris, et al.
Anesthesiology|August 1, 2012
Who is at risk for postdischarge nausea and vomiting after ambulatory surgery?Christian C Apfel, Beverly K Philip, Ozlem S Cakmakkaya, et al.
Chemistry & Biology|June 25, 2009
Substrate-guided design of a potent and selective kallikrein-related peptidase inhibitor for kallikrein 4Joakim E Swedberg, Laura V Nigon, Janet C Reid, et al.
Biochimica Et Biophysica Acta|September 27, 2000
Localization, expression and genomic structure of the gene encoding the human serine protease testisinJ D Hooper, N Bowen, H Marshall, et al.
Oncogene|July 12, 2016
MUC13 protects colorectal cancer cells from death by activating the NF-κB pathway and is a potential therapeutic targetY H Sheng, Y He, S Z Hasnain, et al.
Cellular and Molecular Gastroenterology and Hepatology|September 3, 2023
MUC13 Cell Surface Mucin Limits Salmonella Typhimurium Infection by Protecting the Mucosal Epithelial BarrierMichael A McGuckin, Julie M Davies, Pascal Felgner, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 10, 2025
Antigen presentation potential is variable among human ovarian tumour and syngeneic murine models and dictates pre-clinical outcomes of immunotherapyLouisa Alim, Siddharth Adityan, Rui Chen, et al.
Oncogene|April 1, 2014
EGF inhibits constitutive internalization and palmitoylation-dependent degradation of membrane-spanning procancer CDCP1 promoting its availability on the cell surfaceM N Adams, B S Harrington, Y He, et al.
Pageof 47

Showing results (421-430 of 470) with videos related to

Sort By:
Pageof 47
The Journal of Biological Chemistry|October 16, 1999
The T-superfamily of conotoxinsC S Walker, D Steel, R B Jacobsen, et al.
Frontiers in Neurology|April 1, 2021
Sustained Clinical Improvement in a Subset of Patients With Progressive Multiple Sclerosis Treated With Epstein-Barr Virus-Specific T Cell TherapyZara A Ioannides, Peter A Csurhes, Nanette L Douglas, et al.
Annals of the New York Academy of Sciences|January 1, 1976
Immunochemotherapy of lung cancerT H Stewart, A C Hollinshead, J E Harris, et al.
Anesthesiology|August 1, 2012
Who is at risk for postdischarge nausea and vomiting after ambulatory surgery?Christian C Apfel, Beverly K Philip, Ozlem S Cakmakkaya, et al.
Chemistry & Biology|June 25, 2009
Substrate-guided design of a potent and selective kallikrein-related peptidase inhibitor for kallikrein 4Joakim E Swedberg, Laura V Nigon, Janet C Reid, et al.
Biochimica Et Biophysica Acta|September 27, 2000
Localization, expression and genomic structure of the gene encoding the human serine protease testisinJ D Hooper, N Bowen, H Marshall, et al.
Oncogene|July 12, 2016
MUC13 protects colorectal cancer cells from death by activating the NF-κB pathway and is a potential therapeutic targetY H Sheng, Y He, S Z Hasnain, et al.
Cellular and Molecular Gastroenterology and Hepatology|September 3, 2023
MUC13 Cell Surface Mucin Limits Salmonella Typhimurium Infection by Protecting the Mucosal Epithelial BarrierMichael A McGuckin, Julie M Davies, Pascal Felgner, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 10, 2025
Antigen presentation potential is variable among human ovarian tumour and syngeneic murine models and dictates pre-clinical outcomes of immunotherapyLouisa Alim, Siddharth Adityan, Rui Chen, et al.
Oncogene|April 1, 2014
EGF inhibits constitutive internalization and palmitoylation-dependent degradation of membrane-spanning procancer CDCP1 promoting its availability on the cell surfaceM N Adams, B S Harrington, Y He, et al.
Pageof 47